Abstract Details

Title Lacosamide Efficacy in Partial-Onset Seizures with and without Secondary Generalization: A Pooled Analysis of Three Phase II/III Trials

Topic Epilepsy

Presentation(s) (-)

Poster/Presentation
Number 186

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Jouko I. Isojarvi, MD, PhD (Lundbeck)	No disclosure on file
Felix Rosenow, MD	No disclosure on file
R E. Faught, Jr., MD, FAAN (Emory University)	Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. The institution of Dr. Faught has received research support from Cognizance.
	No disclosure on file
Jacob C. Rube, MD (University Health Center)	Dr. Rube has nothing to disclose.
Pamela Doty, PhD	No disclosure on file

��ɫ��